| Q24544663 | A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma |
| Q91654805 | Ablative therapies for hepatic and biliary tumors: endohepatology coming of age |
| Q34977157 | Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model |
| Q41962614 | Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| Q30479629 | Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma |
| Q78045251 | B7-1 (CD80)-gene transfer combined with interleukin-12 administration elicits protective and therapeutic immunity against mouse hepatocellular carcinoma |
| Q33432267 | Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma. |
| Q37072699 | CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial. |
| Q37278046 | Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion. |
| Q34922680 | Chemoembolization of hepatocellular carcinoma |
| Q29616866 | Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver |
| Q53452462 | Clinical outcome of hepatectomy for hepatocellular carcinomas≤2 cm |
| Q39485505 | Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis |
| Q40339271 | Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion |
| Q37231797 | Combined radiofrequency ablation and acetic acid hypertonic saline solution instillation: an in vivo study of rabbit liver |
| Q44661193 | Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver |
| Q30410578 | Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors |
| Q35962165 | Current and future treatment modalities for hepatocellular carcinoma |
| Q43652306 | Cutaneous seeding after ultrasound-guided percutaneous ethanol injection for treatment of hepatocellular carcinoma. |
| Q31911652 | Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients |
| Q71660134 | Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma |
| Q73031836 | Effect of injection speed on the spread of ethanol during experimental liver ethanol injections |
| Q45362610 | Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma |
| Q36093366 | Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma |
| Q71511063 | Estimation of volumes of distribution and intratumoral ethanol concentrations by computed tomography scanning after percutaneous ethanol injection |
| Q36834223 | Ethanol injection for the treatment of hepatic tumours |
| Q35171592 | Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. |
| Q41109723 | Etiology, screening, and treatment of hepatocellular carcinoma |
| Q34672331 | Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma. |
| Q33601735 | Hepatocellular carcinoma |
| Q44124162 | Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy |
| Q83710870 | Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors |
| Q38079941 | Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors. |
| Q34390851 | Image-guided radiofrequency tumor ablation: challenges and opportunities--part II. |
| Q31161842 | Image-guided tumor ablation: standardization of terminology and reporting criteria |
| Q86095472 | Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update |
| Q48027890 | In vivo assessment of angioarchitecture and microcirculation in experimental liver cancer: a new model in rats |
| Q30887510 | Interstitial ablative techniques for hepatic tumours |
| Q31152537 | Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma |
| Q30883217 | Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients |
| Q36844835 | Interstitial therapies for liver tumors. |
| Q53376428 | Intraarterial infusion of dibutyryl cyclic adenosine monophosphate plus mitomycin C for unresectable hepatocellular carcinoma: long-term survival and response to tumor growth inhibition. |
| Q51590696 | Intralesional ethanol in the treatment of unresectable liver cancer. |
| Q74823648 | Laparoscopic US-guided percutaneous ethanol ablation of hepatocellular carcinoma |
| Q51543456 | Laparoscopic microwave coagulation therapy for solitary hepatocellular carcinoma performed under laparoscopic ultrasonography. |
| Q34027985 | Localized hepatocellular carcinoma: therapeutic options |
| Q32059980 | Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies |
| Q31046676 | Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective |
| Q77839497 | Long-term follow-up arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma |
| Q51239125 | Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation. |
| Q33788290 | Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm |
| Q37155074 | Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea |
| Q36818512 | Magnetic resonance guidance of percutaneous ethanol injection in liver |
| Q36224402 | Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver |
| Q37920769 | Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review |
| Q48145022 | Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy. |
| Q32057774 | New applications of ultrasonography: interventional ultrasound. |
| Q33185268 | New interventions for liver tumors |
| Q30448048 | New paradigm for management of hepatocellular carcinoma by imaging |
| Q36801790 | One-shot percutaneous ethanol injection of liver tumors under general anesthesia: preliminary data on efficacy and complications |
| Q84015567 | Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: confirming the trial that will never be, and some comments on the indications for liver resection |
| Q55487080 | Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery. |
| Q24630594 | Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors |
| Q43615280 | Percutaneous ethanol injection therapy for liver tumors |
| Q46562231 | Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. |
| Q35059537 | Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma |
| Q46198000 | Percutaneous ethanol instillation therapy for hepatocellular carcinoma - a randomized controlled trial. |
| Q31128451 | Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future |
| Q77681896 | Percutaneous mitoxantrone injection for primary and secondary liver tumors: preliminary results |
| Q34390771 | Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases |
| Q44786117 | Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection |
| Q53653808 | Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. |
| Q43753018 | Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients |
| Q79390690 | Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers |
| Q42447533 | Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients |
| Q55413368 | Preliminary study of percutaneous alcohol injection into the lung. |
| Q78147884 | Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma |
| Q35535968 | Presentation and outcomes of hepatocellular carcinoma patients at a western centre |
| Q35648697 | Prevention and treatment of hepatocellular carcinoma |
| Q33805803 | Principles of and advances in percutaneous ablation. |
| Q78056909 | Prognosis of small hepatocellular carcinoma after laparoscopic ethanol injection |
| Q35036657 | Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization |
| Q35597216 | Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients |
| Q48560911 | Proposed abdominal sonographic staging to predict severity of liver diseases: analysis with peritoneoscopy and histology |
| Q34507541 | Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection |
| Q50914834 | Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. |
| Q77872318 | Radiofrequency ablation followed by resection of malignant liver tumors |
| Q83182890 | Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations |
| Q34702909 | Radiofrequency ablation of unresectable primary liver cancer |
| Q35166558 | Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials |
| Q35598182 | Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less |
| Q90447802 | Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies |
| Q77486124 | Relapsing neoplastic seeding after percutaneous ethanol injection for hepatocellular carcinoma. Clinical and ultrasonographic findings in a cirrhotic patient |
| Q42606941 | Retrospective evaluation of tumor-mass-reduction therapy for the prognosis of recurrent hepatocellular carcinoma |
| Q35145063 | Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma |
| Q50960017 | Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection. |
| Q73031845 | Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation |
| Q40489753 | Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates |
| Q37988322 | Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines |
| Q73504047 | Severe gastric mucosa injury after percutaneous pure ethanol injection therapy for hepatocellular carcinoma |
| Q35242650 | Similar local control between phenol- and ethanol-treated giant cell tumors of bone |
| Q77807976 | Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression |
| Q33545658 | Small nodular hepatocellular carcinoma treated by laser thermal ablation in high risk locations: preliminary results |
| Q35161002 | Successful removal of a giant skull base metastasis from hepatocellular carcinoma after direct ethanol injection: case report |
| Q37727030 | Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation |
| Q33400353 | Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma. |
| Q31004882 | The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours |
| Q74037360 | The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis |
| Q58787250 | The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis |
| Q33635364 | Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
| Q35833142 | Treatment and clinical outcome of needle-track seeding from hepatocellular carcinoma |
| Q41640042 | Treatment of hepatocellular carcinoma in patients with cirrhosis |
| Q83196334 | Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation |
| Q50769436 | Ultrasound monitoring of experimental ethanol injection into pig liver. |
| Q51370765 | Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. |
| Q73006912 | Use of FDP and F1P aldolase to detect tumorous and nontumorous tissue damage by ethanol injection of hepatocellular carcinoma |
| Q43565412 | Value of three-dimensional US for optimizing guidance for ablating focal liver tumors |
| Q34379306 | Viruses and hepatocellular carcinoma |
| Q74236226 | [Diagnosis and therapy of hepatocellular carcinoma] |